Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) — Financial Flexibility Index
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of CN¥24.82 Million (operating CF CN¥15.57 Million minus capex CN¥9.26 Million) represents 0% of total liabilities (CN¥373.70 Million). Check 002932 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A across 15 annual periods. See 002932 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2011–2025)
Year-by-year free cash flow to debt coverage for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A. For the full company profile including market capitalisation, see how much is Wuhan Easy Diagnosis Biomedicine Co Ltd worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | CN¥20.84 Million | CN¥-70.05 Million | CN¥324.56 Million | ▼ -63.0% |
| 2024 | 0.17x | CN¥99.72 Million | CN¥-85.05 Million | CN¥574.40 Million | ▼ -62.2% |
| 2023 | 0.46x | CN¥502.47 Million | CN¥392.50 Million | CN¥1.09 Billion | ▼ -74.3% |
| 2022 | 1.79x | CN¥4.33 Billion | CN¥4.01 Billion | CN¥2.42 Billion | ▼ -17.6% |
| 2021 | 2.17x | CN¥1.23 Billion | CN¥1.13 Billion | CN¥567.02 Million | ▲ +74.4% |
| 2020 | 1.24x | CN¥387.97 Million | CN¥359.68 Million | CN¥311.77 Million | ▼ -47.9% |
| 2019 | 2.39x | CN¥54.42 Million | CN¥22.49 Million | CN¥22.80 Million | ▼ -42.1% |
| 2018 | 4.12x | CN¥101.15 Million | CN¥53.67 Million | CN¥24.55 Million | ▼ -39.1% |
| 2017 | 6.76x | CN¥92.01 Million | CN¥46.50 Million | CN¥13.60 Million | ▲ +50.6% |
| 2016 | 4.49x | CN¥99.13 Million | CN¥58.86 Million | CN¥22.07 Million | ▲ +80.5% |
| 2015 | 2.49x | CN¥46.20 Million | CN¥45.02 Million | CN¥18.57 Million | ▲ +37.2% |
| 2014 | 1.81x | CN¥20.71 Million | CN¥16.47 Million | CN¥11.42 Million | ▲ +104.7% |
| 2013 | 0.89x | CN¥9.03 Million | CN¥6.30 Million | CN¥10.19 Million | ▲ +77.3% |
| 2012 | 0.50x | CN¥1.62 Million | CN¥1.03 Million | CN¥3.23 Million | ▲ +369.2% |
| 2011 | -0.19x | CN¥-359.32K | CN¥-482.90K | CN¥1.94 Million | — |